Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Opioid Training Initiative: Opioid Overdose Prevention & Response Training


Opioid Overdose Prevention & Response Training

This Opioid Training Initiative course was developed to prepare healthcare professionals to prevent opioid overdose deaths through patient education and naloxone distribution. After completing this course, you will be able to describe the triple wave opioid crisis, identify risk factors for opioid overdose and provide naloxone to appropriate individuals with pertinent education.
The information in this course has been specifically tailored to meet the needs of clinicians practicing in Texas with a focus on regional trends, laws and regulations.


Lucas G. Hill, PharmD, BCPS, BCACP
Clinical Assistant Professor, The University of Texas at Austin College of Pharmacy
Director, Pharmacy Addictions Research & Medicine (PhARM) Program


Lucas G. Hill, PharmD, BCPS, BCACP, graduated from the University of Missouri-Kansas City School of Pharmacy and completed a combined family medicine residency and faculty development fellowship in the University of Pittsburgh Medical Center St. Margaret Department of Family Medicine. He is now a clinical assistant professor at The University of Texas at Austin (UT) College of Pharmacy. Dr. Hill is the director and principal investigator of Operation Naloxone, an interprofessional opioid overdose prevention program funded through the Texas Targeted Opioid Response. His research is focused on clinician-community collaborations to address substance use disorders through evidence-based treatment and harm reduction strategies. Dr. Hill coordinates the first year of the UT Foundations for Interprofessional Collaborative Practice curriculum and serves as lead instructor for a module that trains students from pharmacy, medicine, nursing, and social work to provide team-based care for patients with addiction. He provides an additional 16 hours of addiction-related instruction in the required pharmacy curriculum and precepts both the overdose prevention introductory pharmacy practice experience and the addiction medicine advanced pharmacy practice experience. Dr. Hill currently serves as chair-elect of the American Association of Colleges of Pharmacy Substance Use Disorder Special Interest Group. He is also faculty advisor for the UT Student Pharmacist Recovery Network and co-chair for the UT Opioid Response Consortium. In 2020, Dr. Hill was awarded the American Pharmacists Association Generation Rx Award of Excellence in recognition of his outstanding contributions to addiction-related education.


DISCLOSURE: Dr. Hill receives financial support from the Substance Abuse and Mental Health Services Administration and the Texas Health and Human Services Commission via the Texas Targeted Opioid Response.

Learning Objectives

  • List the names of commonly used opioid agonists
  • Describe drug overdose trends in the U.S. since 1999
  • Recognize signs and symptoms of an opioid overdose
  • Identify common risk factors for opioid overdose
  • Describe the role of naloxone in overdose response
  • List the core components of a naloxone access law
  • Distinguish between the four naloxone formulations which are appropriate for layperson administration
  • Practice responding to a suspected opioid overdose
  • Prepare to educate patients and community members by answering a list of frequently asked questions

Continuing Education Information


The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This online activity is approved for 0.1 CEUs (1.00 contact hour) of continuing education credit. In order to receive 1.00 contact hour of CE credit, the participant must watch the video in its entirety, complete the online post-test, and complete online evaluation.  Please make sure NABP profile and date of birth (month/year) are correct under learner's profile in this system.

Note: This progam may be counted as one hour of CE related to Prescribing and Monitoring Controlled Subtances, as outlined by (TSBP rule 295.8(d)(1)(C)) and (TMB criteria).

The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Long School of Medicine designates this material for a maximum of 1.0 AMA PRA Category 1 Credit™  .    

NURSING: PLEASE NOTE: This activity expires August 26, 2025 and after that time, even if the course is still accessible it cannot be used for nursing continuing education credits. UT Austin School of Nursing Accredited Provider Unit is not responsible for any use of the program beyond its expiration date.

Accreditation Statement: University of Texas at Austin School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Requirements for Successful Completion: To receive contact hours for this continuing education activity, the participant must register for the course, attend the entire activity, and complete and submit the evaluation form. Once successful completion has been verified, a “Certificate of Successful Completion” will be awarded for 1.0 contact hours.

Conflicts of Interest: The activity’s Nurse Planner has determined that no one who has the ability to control the content of this CNE activity – planning committee members and presenters/authors/content reviewers – has a conflict of interest.    This project is funded by Texas Health & Human Services Texas Targeted Opioid Response. 

Education Disclaimer:  The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice. Activities produced by UT Austin School of Nursing are intended solely for purposes of supplementing health care professionals’ knowledge. The opinions expressed in this educational activity are those of the speaker and do not necessarily represent the views of The University of Texas at Austin School of Nursing.

The Office of Professional Development at The University of Texas at Austin Steve Hicks School of Social Work is accredited by the Council on Social Work Education, and as such receives automatic approval as a continuing education provider by the Texas Board of Social Work Examiners under Texas Administrative Code, Title 22, Part 34. § 781.511(c). The program represented by this certificate was provided in accordance with the criteria and standards of the Texas State Board of Social Worker Examiners, and has been approved for Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists.  Please note that 1 hour = 1 CEU.  Complaints about this program may be made to TSBSWE  333 Guadalupe St, Tower 3, Room 900, Austin, TX 78701  •  512-305-7700 • 800-821-3205

This project is funded by Texas Health & Human Services Texas Targeted Opioid Response.



CE Hours


CE Units


Activity Type

  • Knowledge

Target Audience(s)

  • Advance Practice Nurses (CME)
  • Counselors
  • Nurses
  • Pharmacists
  • Pharmacy Technicians
  • Physician Assistant
  • Physicians
  • Psychiatrists
  • Social Workers
  • Nurse Practitoners (CME)


UT Austin College of Pharmacy Operation Naloxone




Opioid Overdose Prevention & Response Training

Lucas G. Hill, PharmD, BCACP
Clinical Assistant Professor, The University of Texas at Austin College of Pharmacy
Director, Pharmacy Addictions Research & Medicine (PhARM) Program
Upon registration / log in - the video will appear below.

Activity Number


Release Date: Aug 1, 2020
Credit Expiration Date: Aug 1, 2025

CE Hours